Blend of Peptides: GHK-CU, BPC-157, TB-500, KPV & KLOW

The GHK-CU/BPC-157/TB-500/KPV KLOW Blend is a specialized peptide formulation designed for https://henriksen-powell-2.blogbright.net advanced regenerative and anti-inflammatory therapy.

The GHK-CU/BPC-157/TB-500/KPV KLOW Blend is a specialized peptide formulation designed for advanced regenerative and anti-inflammatory therapy. It combines four potent peptides—GHK-Copper (Cu), Body Protective Compound 157 (BPC-157), Testosteron-Boosting Peptide 500 (TB-500), and KPV—into a single, stable liquid that is marketed to practitioners seeking synergistic healing benefits.


Description

The blend harnesses the unique properties of each constituent peptide. GHK-Cu, a copper-binding hexapeptide, is known for its collagen stimulation, wound repair, and anti-oxidant effects. BPC-157, derived from a human gastric protein, promotes rapid tissue regeneration, improves blood flow, and reduces inflammation in muscle, tendon, ligament, nerve, and bone injuries. TB-500, a fragment of thymosin beta-4, enhances cellular migration, angiogenesis, and https://henriksen-powell-2.blogbright.net soft tissue healing while modulating inflammatory pathways. KPV, a tripeptide derived from the endogenous protein prokineticin, exhibits potent anti-inflammatory action, reduces edema, and protects tissues against oxidative damage. Together these peptides act on complementary mechanisms to accelerate recovery, reduce pain, and restore functional integrity in musculoskeletal injuries, chronic inflammation, and even certain metabolic disorders.


The product is supplied as a sterile, ready-to-inject solution that can be used subcutaneously or intramuscularly depending on the clinical protocol. The formulation includes stabilizing excipients to maintain peptide integrity over an extended shelf life. It is typically packaged in 1 ml vials with a 30 µl syringe for precise dosing.


Product Specifications


• Active Ingredients

  • GHK-Cu: 0.5 mg per vial

  • BPC-157: 0.3 mg per vial

  • TB-500: 0.2 mg per vial

  • KPV: 0.1 mg per vial


• Concentration: 0.5 mg/ml total peptide concentration, with each peptide at its respective proportion.


• Volume: 1 ml per vial (30 µl injection volume).


• Sterility: USP-classified sterile solution, free from pyrogens and endotoxins.


• pH: 7.4 ± 0.2, compatible with physiological conditions.


• Storage Conditions: Store at 2–8°C in a refrigerator; protect from direct light by keeping the vial in its original packaging. The product is stable for 12 months when stored under these conditions.


• Shelf Life: 12 months from manufacture date when kept refrigerated.


• Packaging: Each vial sealed with a sterile, single-use needle and syringe (30 µl).

  • Labeling includes batch number, expiration date, lot code, and storage instructions.


• Regulatory Status: The blend is marketed as an investigational or research compound in many jurisdictions; it is not approved by major regulatory bodies for clinical use outside of controlled studies.


• Suggested Use Protocols

- For acute tendon or ligament injury: 30 µl subcutaneous injection daily for 7–14 days, followed by a tapering schedule over the next month.

- For chronic inflammation or arthritis: 30 µl intramuscular injection twice weekly for 4 weeks, with monitoring of inflammatory markers.

- For wound healing enhancement: Apply 30 µl subcutaneously near the injury site daily until closure is observed.


• Precautions and Contraindications

- Not recommended during pregnancy or lactation without specialist consultation.

- Individuals with known hypersensitivity to any component should avoid use.

- Must be used under medical supervision due to potential systemic effects of peptide hormones.


The GHK-CU/BPC-157/TB-500/KPV KLOW Blend offers a multifaceted approach to tissue repair and inflammation control, making it an attractive option for clinicians and researchers focused on cutting-edge regenerative medicine.


shogrover3982

1 Blog posts

Comments